Kasper, Siegfried

Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET

Baldinger, P., Kranz, G. S., Haeusler, D., Savli, M., Spies, M., Philippe, C., Hahn, A., Höflich, A., Wadsak, W., Mitterhauser, M., et al. (2014) · NeuroImage

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 67

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study

Dold, M., Kautzky, A., Bartova, L., Rabl, U., Souery, D., Mendlewicz, J., Porcelli, S., Serretti, A., Zohar, J., Montgomery, S., et al. (2016) · European Neuropsychopharmacology

Treatment of Major DepressionMental Health Treatment and Access

Cited by 66

Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression

Hahn, A., Haeusler, D., Kraus, C., Höflich, A. S., Kranz, G. S., Baldinger, P., Savli, M., Mitterhauser, M., Wadsak, W., Karanikas, G., et al. (2014) · Human Brain Mapping

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 66

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study

Klein, N., Sacher, J., Geiss-Granadia, T., Mossaheb, N., Attarbaschi, T., Lanzenberger, R., Spindelegger, C., Holik, A., Asenbaum, S., Dudczak, R., et al. (2007) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 62

The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography

Vanicek, T., Spies, M., Rami-Mark, C., Savli, M., Höflich, A., Kranz, G. S., Hahn, A., Kutzelnigg, A., Traub-Weidinger, T., Mitterhauser, M., et al. (2014) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 61

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

Fabbri, C., Kasper, S., Kautzky, A., Bartova, L., Dold, M., Zohar, J., Souery, D., Montgomery, S., Albani, D., Raimondi, I., et al. (2019) · British Journal of Psychiatry

Treatment of Major DepressionGenetic Associations and Epidemiology

Cited by 61

Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake

Kraus, C., Ganger, S., Losak, J., Hahn, A., Savli, M., Kranz, G. S., Baldinger, P., Windischberger, C., Kasper, S., & Lanzenberger, R. (2014) · NeuroImage

Functional Brain Connectivity StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 54

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study

Stamenkovic, M., Schindler, S. D., Asenbaum, S., Neumeister, A., Willeit, M., Willinger, U., de Zwaan, M., Riederer, F., Aschauer, H. N., & Kasper, S. (2001) · European Neuropsychopharmacology

Obsessive-Compulsive Spectrum DisordersNeurotransmitter Receptor Influence on Behavior

Cited by 52

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study

Meyer, B. M., Rabl, U., Huemer, J., Bartova, L., Kalcher, K., Provenzano, J., Brandner, C., Sezen, P., Kasper, S., Schatzberg, A. F., et al. (2019) · Translational Psychiatry

Treatment of Major DepressionNeural and Behavioral Psychology Studies

Cited by 52

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET

Sigurdardottir, H. L., Kranz, G. S., Rami‐Mark, C., James, G. M., Vanicek, T., Gryglewski, G., Kautzky, A., Hienert, M., Traub‐Weidinger, T., Mitterhauser, M., et al. (2016) · Human Brain Mapping

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 51

Voxel-based morphometry at ultra-high fields. A comparison of 7T and 3T MRI data

Seiger, R., Hahn, A., Hummer, A., Kranz, G. S., Ganger, S., Küblböck, M., Kraus, C., Sladky, R., Kasper, S., Windischberger, C., et al. (2015) · NeuroImage

Advanced MRI Techniques and ApplicationsAdvanced Neuroimaging Techniques and Applications

Cited by 48

Psychiatric patients' perception of physical restraint

Fugger, G., Gleiss, A., Baldinger, P., Strnad, A., Kasper, S., & Frey, R. (2016) · Acta Psychiatrica Scandinavica

Healthcare Decision-Making and RestraintsRestraint-Related Deaths

Cited by 48

Gender-specific symptoms of depression and anger attacks

Winkler, D., Pjrek, E., & Kasper, S. (2006) · The Journal of Men's Health & Gender

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 47

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

Calati, R., Crisafulli, C., Balestri, M., Serretti, A., Spina, E., Calabrò, M., Sidoti, A., Albani, D., Massat, I., Höfer, P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 45

Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET: Serotonin Transporter in ADHD Revealed by PET

Vanicek, T., Kutzelnigg, A., Philippe, C., Sigurdardottir, H. L., James, G. M., Hahn, A., Kranz, G. S., Höflich, A., Kautzky, A., Traub-Weidinger, T., et al. (2017) · Human Brain Mapping

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 44

Dose escalation of antidepressants in unipolar depression: a meta-analysis of double-blind, randomized controlled trials

Dold, M., Bartova, L., Rupprecht, R., & Kasper, S. (2017) · Psychotherapy and Psychosomatics

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 38

Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine

Kasper, S., Möller, H. J., Montgomery, S. A., & Zondag, E. (1995) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 37

Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial

Höflich, A., Kraus, C., Pfeiffer, R. M., Seiger, R., Rujescu, D., Zarate, C. A., Kasper, S., Winkler, D., & Lanzenberger, R. (2021) · Translational Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 34

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography

Spies, M., James, G. M., Berroterán-Infante, N., Ibeschitz, H., Kranz, G. S., Unterholzner, J., Godbersen, M., Gryglewski, G., Hienert, M., Jungwirth, J., et al. (2018) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 34

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

Dold, M., Bartova, L., & Kasper, S. (2020) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 34

Reconceptualising treatment‐resistant depression as difficult‐to‐treat depression

McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2021) · The Lancet Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 30

Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression

Bartova, L., Fugger, G., Dold, M., Swoboda, M. M. M., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., et al. (2021) · Journal of Psychiatric Research

Treatment of Major DepressionPsychotherapy Techniques and Applications

Cited by 25

Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy

Winkler, D., Pjrek, E., Lanzenberger, R., Baldinger, P., Eitel, D., Kasper, S., & Frey, R. (2014) · Journal of Psychiatric Research

Electroconvulsive Therapy StudiesTreatment of Major Depression

Cited by 21

Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study

Wajs, E., Leah, A., Morrison, R., Daly, E., Lane, R., Lim, P., Holder, R., Sanacora, G., Young, A. H., Kasper, S., et al. (2019) · European Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 19